InvestorsHub Logo
Followers 1
Posts 270
Boards Moderated 0
Alias Born 10/05/2006

Re: powerbattles post# 705

Monday, 05/10/2010 11:32:57 AM

Monday, May 10, 2010 11:32:57 AM

Post# of 774
I was until today. I used to post on another Investor Board agoracom.com However ALRX stopped paying them and the board was blocked. I having been following ALRX for years and I hope they can get support for Indaflex again. It seemed to be a great product and made it to Phase II. They do have other products so we shall wait and see.

HONG KONG, May 10 /PRNewswire-FirstCall/ - AlphaRx, Inc. (OTCBB: ALRX.OB), has been advised by Cypress Biosciences ("Cypress"), its development partner for Indaflex, that Cypress is not funding development of Indaflex. Notwithstanding to the termination of all Indaflex activity in the U.S.A., AlphaRx continues to develop Indaflex for the Chinese market. AlphaRx is working diligently with its regulatory consultants in the preparation for submission of a CTA (clinical Trial Application) with the China SFDA in order to begin human trials in China. These preparations are proceeding on schedule.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.